99 related articles for article (PubMed ID: 10431804)
1. Expression of a functionally active human hepatic UDP-glucuronosyltransferase (UGT1A6) lacking the N-terminal signal sequence in the endoplasmic reticulum.
Ouzzine M; Magdalou J; Burchell B; Fournel-Gigleux S
FEBS Lett; 1999 Jul; 454(3):187-91. PubMed ID: 10431804
[TBL] [Abstract][Full Text] [Related]
2. An internal signal sequence mediates the targeting and retention of the human UDP-glucuronosyltransferase 1A6 to the endoplasmic reticulum.
Ouzzine M; Magdalou J; Burchell B; Fournel-Gigleux S
J Biol Chem; 1999 Oct; 274(44):31401-9. PubMed ID: 10531341
[TBL] [Abstract][Full Text] [Related]
3. Photoaffinity labeling of the aglycon binding site of the recombinant human liver UDP-glucuronosyltransferase UGT1A6 with 7-azido-4-methylcoumarin.
Senay C; Battaglia E; Chen G; Breton R; Fournel-Gigleux S; Magdalou J; Radominska-Pandya A
Arch Biochem Biophys; 1999 Aug; 368(1):75-84. PubMed ID: 10415114
[TBL] [Abstract][Full Text] [Related]
4. The importance of cysteine 126 in the human liver UDP-glucuronosyltransferase UGT1A6.
Senay C; Jedlitschky G; Terrier N; Burchell B; Magdalou J; Fournel-Gigleux S
Biochim Biophys Acta; 2002 May; 1597(1):90-6. PubMed ID: 12009407
[TBL] [Abstract][Full Text] [Related]
5. Carrier-mediated transport of uridine diphosphoglucuronic acid across the endoplasmic reticulum membrane is a prerequisite for UDP-glucuronosyltransferase activity in rat liver.
Bossuyt X; Blanckaert N
Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):645-8. PubMed ID: 9169596
[TBL] [Abstract][Full Text] [Related]
6. A membrane transporter mediates access of uridine 5'-diphosphoglucuronic acid from the cytosol into the endoplasmic reticulum of rat hepatocytes: implications for glucuronidation reactions.
Hauser SC; Ziurys JC; Gollan JL
Biochim Biophys Acta; 1988 Nov; 967(2):149-57. PubMed ID: 3142526
[TBL] [Abstract][Full Text] [Related]
7. Activation of glucuronidation through reduction of a disulfide bond in rat UDP-glucuronosyltransferase 1A6.
Ikushiro S; Emi Y; Iyanagi T
Biochemistry; 2002 Oct; 41(42):12813-20. PubMed ID: 12379124
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the Endoplasmic Reticulum Localization of UDP-Glucuronosyltransferase 2B7 with Systematic Deletion Mutants.
Miyauchi Y; Kimura S; Kimura A; Kurohara K; Hirota Y; Fujimoto K; Mackenzie PI; Tanaka Y; Ishii Y
Mol Pharmacol; 2019 May; 95(5):551-562. PubMed ID: 30944207
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of human and cynomolgus monkey UDP-glucuronosyltransferase 1A6 enzymes.
Hanioka N; Takeda Y; Jinno H; Tanaka-Kagawa T; Naito S; Koeda A; Shimizu T; Nomura M; Narimatsu S
Chem Biol Interact; 2006 Dec; 164(1-2):136-45. PubMed ID: 17027947
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of 5-hydroxytryptophol and other endogenous serotonin (5-hydroxytryptamine) analogs as substrates for UDP-glucuronosyltransferase 1A6.
Krishnaswamy S; Hao Q; Von Moltke LL; Greenblatt DJ; Court MH
Drug Metab Dispos; 2004 Aug; 32(8):862-9. PubMed ID: 15258112
[TBL] [Abstract][Full Text] [Related]
11. The carboxyl-terminal di-lysine motif is essential for catalytic activity of UDP-glucuronosyltransferase 1A9.
Miyauchi Y; Kurohara K; Kimura A; Esaki M; Fujimoto K; Hirota Y; Takechi S; Mackenzie PI; Ishii Y; Tanaka Y
Drug Metab Pharmacokinet; 2020 Oct; 35(5):466-474. PubMed ID: 32883578
[TBL] [Abstract][Full Text] [Related]
12. Role of the carboxyl terminal stop transfer sequence of UGT1A6 membrane protein in ER targeting and translocation of upstream lumenal domain.
Ouzzine M; Barré L; Netter P; Magdalou J; Fournel-Gigleux S
FEBS Lett; 2006 Apr; 580(8):1953-8. PubMed ID: 16529747
[TBL] [Abstract][Full Text] [Related]
13. The "albumin effect" and drug glucuronidation: bovine serum albumin and fatty acid-free human serum albumin enhance the glucuronidation of UDP-glucuronosyltransferase (UGT) 1A9 substrates but not UGT1A1 and UGT1A6 activities.
Rowland A; Knights KM; Mackenzie PI; Miners JO
Drug Metab Dispos; 2008 Jun; 36(6):1056-62. PubMed ID: 18362158
[TBL] [Abstract][Full Text] [Related]
14. Deferiprone glucuronidation by human tissues and recombinant UDP glucuronosyltransferase 1A6: an in vitro investigation of genetic and splice variants.
Benoit-Biancamano MO; Connelly J; Villeneuve L; Caron P; Guillemette C
Drug Metab Dispos; 2009 Feb; 37(2):322-9. PubMed ID: 18971318
[TBL] [Abstract][Full Text] [Related]
15. UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: I. Identification of polymorphisms in the 5'-regulatory and exon 1 regions, and association with human liver UGT1A6 gene expression and glucuronidation.
Krishnaswamy S; Hao Q; Al-Rohaimi A; Hesse LM; von Moltke LL; Greenblatt DJ; Court MH
J Pharmacol Exp Ther; 2005 Jun; 313(3):1331-9. PubMed ID: 15761114
[TBL] [Abstract][Full Text] [Related]
16. A mutation which disrupts the hydrophobic core of the signal peptide of bilirubin UDP-glucuronosyltransferase, an endoplasmic reticulum membrane protein, causes Crigler-Najjar type II.
Seppen J; Steenken E; Lindhout D; Bosma PJ; Elferink RP
FEBS Lett; 1996 Jul; 390(3):294-8. PubMed ID: 8706880
[TBL] [Abstract][Full Text] [Related]
17. Molecular cloning and functional analysis of minipig UDP-glucuronosyltransferase 1A6.
Miyake Y; Hirose R; Isobe T; Hanioka N
Xenobiotica; 2016; 46(3):193-9. PubMed ID: 26134041
[TBL] [Abstract][Full Text] [Related]
18. Importance of histidine residues for the function of the human liver UDP-glucuronosyltransferase UGT1A6: evidence for the catalytic role of histidine 370.
Ouzzine M; Antonio L; Burchell B; Netter P; Fournel-Gigleux S; Magdalou J
Mol Pharmacol; 2000 Dec; 58(6):1609-15. PubMed ID: 11093802
[TBL] [Abstract][Full Text] [Related]
19. Characterizing the effects of common UDP glucuronosyltransferase (UGT) 1A6 and UGT1A1 polymorphisms on cis- and trans-resveratrol glucuronidation.
Iwuchukwu OF; Ajetunmobi J; Ung D; Nagar S
Drug Metab Dispos; 2009 Aug; 37(8):1726-32. PubMed ID: 19406951
[TBL] [Abstract][Full Text] [Related]
20. An alternative promoter contributes to tissue- and inducer-specific expression of the rat UDP-glucuronosyltransferase 1A6 gene.
Auyeung DJ; Kessler FK; Ritter JK
Toxicol Appl Pharmacol; 2001 Jul; 174(1):60-8. PubMed ID: 11437649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
